ArticleBMC infectious diseases2025
Machine learning-based prediction of mortality and multidrug-resistant infection risks in ICU patients with suspected infection: a prospective national multicenter cohort study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04966390 (A Prospective,Multicenter,Non-interventional Real-world Study for Standardized Clinical Application of Antibacterial/Anitifungal Drugs), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Prospective,Multicenter,Non-interventional Real-world Study for Standardized Clinical Application of Antibacterial/Anitifungal Drugs
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundSuspected infection can progress to sepsis or septic shock, contributing to a high mortality rate among patients admitted to ICU. However, the characteristics of suspected infection remain incompletely defined. We aimed to develop and validate predictive models to identify independent risk factors for mortality and multidrug-resistant infection in patients with suspected infection upon ICU admission in mainland China.
methodsWe prospectively collected medical data from patients with suspected infection admitted to ICUs across mainland China between July 2021 and December 2022. Patients were randomly allocated to a training cohort and a validation cohort at a 7:3 ratio. Using machine learning algorithms, we identified risk factors and constructed predictive models for mortality and multidrug-resistant infection. The performance of models developed by logistic regression, random forest, extreme gradient boosting, and gradient boosting machine was evaluated using the area under the curve (AUC), Brier score, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), the Youden index, net reclassification improvement (NRI), and integrated discrimination improvement (IDI).
resultsA total of 2963 patients from 67 hospitals in mainland China were enrolled. The most common infection sites were the lung (79.28%), bloodstream (17.11%) and abdomen (16.54%). The overall mortality rate was 10.90%. The logistic regression model demonstrated the best performance for mortality prediction (AUC 0.87) and identified the following risk factors: surgery (2.39, 95CI% 1.60–3.56, p < 0.01), APACHE II score (1.51, 95CI% 1.44–1.58, p < 0.01), and bloodstream infection (2.08, 95CI% 1.40–3.10, p < 0.01) were independent risk factors of mortality. For multidrug resistant infection prediction, the logistic regression model also showed the highest discriminative ability (AUC 0.86). Independent risk factors included APACHE II score (1.06, 95%CI 1.03–1.1, p < 0.01), bloodstream infection (1.82, 95%CI 1.26–2.61, p < 0.01), urinary infection (3.42, 95%CI 2.20–5.30, p < 0.01), Klebsiella pneumoniae (11.67, 95%CI 7.91–17.21, p < 0.01), Acinetobacter baumannii (85.22, 95%CI 50.03-145.18, p < 0.01), and Enterococcus faecium (22.10, 95%CI 8.58–56.93, p < 0.01).
conclusionsPneumonia was the most common infection among ICU patients in mainland China. Using machine learning techniques, we developed and validated predictive models that identified independent risk factors for mortality and multidrug-resistant infection upon ICU admission. CLINICAL
trial registrationThe trial protocol was registered at ClinicalTrials.gov (Identifier: NCT04966390, Registration Date: July 14, 2021). The full record can be accessed at: https://clinicaltrials.gov/show/NCT04966390 .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.